Monday 9 November 2026 Export LXEO’s income statement to Excel — free account

Lexeo Therapeutics, Inc.

LXEO

Healthcare Biotechnology

Lexeo Therapeutics, Inc.’s revenue for fiscal 2022 (year ended December 2022) was $654,000.00.

EPS: +50.0%
Free cash flow: +35.6%
Total debt: −83.5%

Quarter to June 2026, against a year earlier

2.89 0.02 −0.69%

Follow LXEO

Alert me

Market cap: $237.2M
P/E: n/m
Fwd P/E: n/m
Dividend yield: —
F-score: 4/9
ROIC: −253.5%
Net debt / EBITDA: 1.7×
Dividend safety: n/a

Overview

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	—	—	—	—	+8 more quarters Free account
EV/Sales Full definition →	—	—	—	—
EV/FCF Full definition →	—	—	—	—
Quick Ratio Full definition →	13.49	13.61	10.81	7.11
Current Ratio Full definition →	13.89	14.16	11.21	7.40
Net Debt/EBITDA Full definition →	7.58	8.65	7.88	5.68
Debt/Assets Full definition →	0.04%	0.08%	0.12%	0.32%
Debt/Equity Full definition →	0.00	0.00	0.00	0.00
Asset Turnover Full definition →	0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →	0.68	1.05	0.96	1.46
Capex/Depreciation Full definition →	(0.07)	(1.13)	0.00	(2.17)
Interest Coverage Full definition →	(2,001.43)	(1,313.71)	(1,155.80)	(984.00)
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Yield Full definition →	—	—	—	—
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.21)	(0.26)	(0.37)	(0.48)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.21)	(0.26)	(0.37)	(0.49)
Cash per Share Full definition →	2.47	2.38	3.39	2.01
Shareholders Equity per Share Full definition →	2.75	2.85	4.60	1.98
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	2.75	2.85	4.60	1.98
Free Cash Flow Full definition →	(17.60)	(21.18)	(20.08)	(29.84)
Working Capital Full definition →	202.22	186.67	171.58	110.52
Capital Expenditures Full definition →	(0.01)	(0.03)	0.00	(0.29)
Net Current Asset Value Full definition →	198.07	182.00	166.37	104.78
EV/EBIT Full definition →	—	—	—	—
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Payables Full definition →	12.10	7.66	5.64	6.55
Average Assets Full definition →	215.48	188.02	207.82	158.85
Average Common Equity Full definition →	186.64	159.81	181.76	130.08

Show all line items

Columns are period end dates

Stockrow Weekly